Heterocyclic compounds as inhibitors of hepatitis C virus (HCV)

Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.

Saved in:
Bibliographic Details
Main Authors WOLLER KEVIN R, HUTCHINS CHARLES W, BETEBENNER DAVID A, HUTCHINSON DOUGLAS K, ROCKWAY TODD W, FLENTGE CHARLES A, PATEL SACHIN V, JINKERSON TAMMIE K, SARRIS KATHY, GAO YI, DEGOEY DAVID A, KEDDY RYAN G, KATI WARREN M, MATULENKO MARK A, CALIFANO JEAN C, CASPI DANIEL D, MARING CLARENCE J, PRATT JOHN K, DONNER PAMELA L, NELSON LISSA T, WAGNER ROLF, RANDOLPH JOHN T, TUFANO MICHAEL D, LIU DACHUN, KRUEGER ALLAN C, MOTTER CHRISTOPHER E, WAGAW SEBLE H, LI WENKE, BELLIZZI MARY E
Format Patent
LanguageEnglish
Slovenian
Published 31.03.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
Bibliography:Application Number: SI20100030870T